Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK and Merck to Study Immunotherapy Combination as Potential Cancer Treatment
GSK and Merck to Study Immunotherapy Combination as Potential Cancer Treatment
GSK and Merck to Study Immunotherapy Combination as Potential Cancer Treatment
Submitted by
admin
on November 3, 2015 - 2:17pm
Source:
Yahoo
News Tags:
GSK
Merck
GSK3174998
Keytruda
cancer immunotherapy
Headline:
GSK and Merck to Study Immunotherapy Combination as Potential Cancer Treatment
Do Not Allow Advertisers to Use My Personal information
